1st Quarter - Termination

THE WERNER GROUP for BIOTECHNOLOGY INDUSTRY ORGANIZATION

Firm
Client
Income
$25,000
Expenses
—
Terminated
Feb 28, 2009

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

HR 873, S 487 The Stem Cell Research Enhacement Act of 2009 HR 872, The Stem Cell Research Improvement Act of 2009

LobbyistCovered position, as disclosed
MICHAEL WERNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 873 (111th), H.R. 872 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.